Gates Foundation Strategic Investment Fund Logo
Share this page:

The Sunday Morning Herald: Australian not-for-profit wins unprecedented approval for blindness drug

By Latika Bourke

July 22, 2018

London: An Australian company has won unprecedented US approval for a new drug to treat the second most common preventable cause of blindness in the world.

In the process, Medicines Development for Global Health, based in Melbourne, became the first not-for-profit company in the world to register a medicine with the US Food and Drug Administration.

Read the full text here